These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36248037)

  • 1. Factors Determining Risk Categories in Differentiated Thyroid Carcinoma: Study of an Indian Cohort.
    Chirayath SR; Menon UV; Nair V; Kumar H; Praveen VP; Bhavani N; Abraham N
    Indian J Endocrinol Metab; 2022; 26(3):269-274. PubMed ID: 36248037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcome of differentiated thyroid carcinoma: experience in a developing country.
    Bhargav PR; Mishra A; Agarwal G; Agarwal A; Pradhan PK; Gambhir S; Verma AK; Mishra SK
    World J Surg; 2010 Jan; 34(1):40-7. PubMed ID: 20020292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of histopathological features and prognosis of classical and follicular variant papillary thyroid carcinoma.
    Tunca F; Sormaz IC; Iscan Y; Senyurek YG; Terzioglu T
    J Endocrinol Invest; 2015 Dec; 38(12):1327-34. PubMed ID: 26280320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mutation of RAS gene in follicular-differentiated thyroid tumors and its significance].
    Liu LP; Hao JY; Pan H; Wang C; Yue P
    Zhonghua Bing Li Xue Za Zhi; 2020 Mar; 49(3):256-261. PubMed ID: 32187898
    [No Abstract]   [Full Text] [Related]  

  • 5. The significance of the presence of extranodal extension in the metastatic node of differentiated thyroid cancer: a proposal for modification in the American Thyroid Association (ATA) risk stratification.
    Chidambaranathan N; Thiagarajan S; Gurukeerthi B; Sathe P; Samel P; Ramalingam N; Chaukar D
    Eur Arch Otorhinolaryngol; 2024 Apr; 281(4):1923-1931. PubMed ID: 38189969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ablation therapy using a low dose of radioiodine may be sufficient in low- to intermediate-risk patients with follicular variant papillary thyroid carcinoma.
    Li F; Li W; Gray KD; Zarnegar R; Wang D; Fahey TJ
    J Int Med Res; 2020 Nov; 48(11):300060520966491. PubMed ID: 33213252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papillary thyroid carcinoma micro-deposits in cervical lymph nodes without intra-thyroid malignancy: A comment in consideration of the latest American Thyroid Association guidelines.
    Karvounis E; Kechagias A; Kappas I; Ioakimidou C; Fillipidis T
    Mol Clin Oncol; 2021 Aug; 15(2):164. PubMed ID: 34194742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Incidence of Distant Metastasis Is Associated With Histopathological Subtype of Pediatric Papillary Thyroid Cancer - a Retrospective Analysis Based on SEER.
    Zeng X; Wang Z; Gui Z; Xiang J; Cao M; Sun W; He L; Dong W; Huang J; Zhang D; Lv C; Zhang T; Shao L; Zhang P; Zhang H
    Front Endocrinol (Lausanne); 2021; 12():760901. PubMed ID: 34858334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for central neck lymph node metastases in follicular variant vs. classic papillary thyroid carcinoma.
    Raffaelli M; De Crea C; Sessa L; Fadda G; Lombardi CP; Bellantone R
    Endocrine; 2018 Oct; 62(1):64-70. PubMed ID: 29770933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratumoural lymph vessel density is related to presence of lymph node metastases and separates encapsulated from infiltrative papillary thyroid carcinoma.
    Eloy C; Santos J; Soares P; Sobrinho-Simões M
    Virchows Arch; 2011 Dec; 459(6):595-605. PubMed ID: 22081104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary tumour diameter as a risk factor for advanced disease features of differentiated thyroid carcinoma.
    Verburg FA; Mäder U; Luster M; Reiners C
    Clin Endocrinol (Oxf); 2009 Aug; 71(2):291-7. PubMed ID: 19067727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follicular and Hurthle cell carcinoma of the thyroid in iodine-sufficient area: retrospective analysis of Korean multicenter data.
    Kim WG; Kim TY; Kim TH; Jang HW; Jo YS; Park YJ; Kim SW; Kim WB; Shong M; Park DJ; Chung JH; Shong YK; Cho BY
    Korean J Intern Med; 2014 May; 29(3):325-33. PubMed ID: 24851067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2019 Aug; 29(8):1073-1079. PubMed ID: 31140385
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparing the Prognostic Value of the Eighth Edition of the American Joint Committee on Cancer/Tumor Node Metastasis Staging System Between Papillary and Follicular Thyroid Cancer.
    van Velsen EFS; Stegenga MT; van Kemenade FJ; Kam BLR; van Ginhoven TM; Visser WE; Peeters RP
    Thyroid; 2018 Aug; 28(8):976-981. PubMed ID: 29848239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern).
    Rivera M; Tuttle RM; Patel S; Shaha A; Shah JP; Ghossein RA
    Thyroid; 2009 Feb; 19(2):119-27. PubMed ID: 19191744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role and Extent of Neck Dissection for Neck Lymph Node Metastases in Differentiated Thyroid Cancers.
    Aygun N; Kostek M; Isgor A; Uludag M
    Sisli Etfal Hastan Tip Bul; 2021; 55(4):438-449. PubMed ID: 35317376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
    Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
    J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avidity and Outcomes of Radioiodine Therapy for Distant Metastasis of Distinct Types of Differentiated Thyroid Cancer.
    Simões-Pereira J; Mourinho N; Ferreira TC; Limbert E; Cavaco BM; Leite V
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e3911-e3922. PubMed ID: 34134139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region.
    Passler C; Scheuba C; Prager G; Kaczirek K; Kaserer K; Zettinig G; Niederle B
    Endocr Relat Cancer; 2004 Mar; 11(1):131-9. PubMed ID: 15027890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants.
    Shi X; Liu R; Basolo F; Giannini R; Shen X; Teng D; Guan H; Shan Z; Teng W; Musholt TJ; Al-Kuraya K; Fugazzola L; Colombo C; Kebebew E; Jarzab B; Czarniecka A; Bendlova B; Sykorova V; Sobrinho-Simões M; Soares P; Shong YK; Kim TY; Cheng S; Asa SL; Viola D; Elisei R; Yip L; Mian C; Vianello F; Wang Y; Zhao S; Oler G; Cerutti JM; Puxeddu E; Qu S; Wei Q; Xu H; O'Neill CJ; Sywak MS; Clifton-Bligh R; Lam AK; Riesco-Eizaguirre G; Santisteban P; Yu H; Tallini G; Holt EH; Vasko V; Xing M
    J Clin Endocrinol Metab; 2016 Jan; 101(1):264-74. PubMed ID: 26529630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.